A retrospective analysis of the duration of oral antibiotic therapy for the treatment of acne among adolescents: Investigating practice gaps and potential cost-savings

Journal of the American Academy of Dermatology

Volumn 71, Issue 1, 2014, Pages 70-76

  Lee, Young H ^a   Liu, Guodong ^a   Thiboutot, Diane M ^a   Leslie, Douglas L ^a   Kirby, Joslyn S ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

acne treatment; acne vulgaris; costs; oral antibiotics; topical retinoids; treatment guidelines

Indexed keywords

ANTIBIOTIC AGENT; DOXYCYCLINE; MINOCYCLINE; RETINOID;

ACNE; ADOLESCENT; ADOLESCENT DISEASE; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; COST CONTROL; DISEASE SEVERITY; DRUG COST; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION;

ACNE TREATMENT; ACNE VULGARIS; COSTS; ORAL ANTIBIOTICS; TOPICAL RETINOIDS; TREATMENT GUIDELINES;

ACNE VULGARIS; ADMINISTRATION, ORAL; ADOLESCENT; ANTI-BACTERIAL AGENTS; COST OF ILLNESS; COST SAVINGS; DERMATOLOGY; FEMALE; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84903279007     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2014.02.031     Document Type: Article

References (34)

1. M.T. Johnson, and J. Roberts Skin conditions and related need for medical care among persons 1-74 years. United States, 1971-1974 Vital Health Stat 11 1978 i-v:1-72
2. A.W. Lucky, F.M. Biro, G.A. Huster, A.D. Leach, J.A. Morrison, and J. Ratterman Acne vulgaris in premenarchal girls: an early sign of puberty associated with rising levels of dehydroepiandrosterone Arch Dermatol 130 1994 308 314
3. A.A. Qureshi, I. Freedberg, L. Goldsmith, and A. Moshell Report on "Burden of Skin Disease" workshop; NIAMS, September 2002 J Investig Dermatol Symp Proc 9 2004 111 119
4. H. Gollnick, W. Cunliffe, D. Berson, B. Dreno, A. Finlay, and J.J. Leyden et al. Management of acne: a report from a global alliance to improve outcomes in acne J Am Acad Dermatol 49 Suppl 2003 S1 S37
5. D. Thiboutot, H. Gollnick, V. Bettoli, B. Dreno, S. Kang, and J.J. Leyden et al. New insights into the management of acne: an update from the global alliance to improve outcomes in acne group J Am Acad Dermatol 60 Suppl 2009 S1 S50
6. B. Dreno, V. Bettoli, F. Ochsendorf, A. Layton, H. Mobacken, and H. Degreef European recommendations on the use of oral antibiotics for acne Eur J Dermatol 14 2004 391 399
7. A.L. Zaenglein, and D.M. Thiboutot Expert committee recommendations for acne management Pediatrics 118 2006 1188 1199
8. A. Nast, B. Dreno, V. Bettoli, K. Degitz, R. Erdmann, and A.Y. Finlay et al. European evidence-based (S3) guidelines for the treatment of acne J Eur Acad Dermatol Venereol 26 Suppl 2012 1 29
9. National Institute for Health and Care Excellence. Acne vulgaris. Available from: URL: http://cks.nice.org.uk/acne-vulgaris#!prescribinginfosub: 24. Accessed December 10, 2013.
10. M. Ozolins, E.A. Eady, A. Avery, W.J. Cunliffe, C. O'Neill, and N.B. Simpson et al. Randomized controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne Health Technol Assess 9 2005 iii-212
11. M. Alirezai, S.A. George, I. Coutts, D.I. Roseeuw, J.P. Hachem, and N. Kerrouche et al. Daily treatment with adapalene gel 0.1% maintains initial improvement of acne vulgaris previously treated with oral lymecycline Eur J Dermatol 17 2007 45 51
12. B. Dreno, R. Kaufmann, S. Talarico, V. Torres Lozada, M.A. Rodriguez-Castellanos, and M. Gomez-Flores et al. Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicenter, randomized, double-blind controlled study Br J Dermatol 165 2011 383 390
13. Y. Poulin, N.P. Sanchez, A. Bucko, J. Fowler, M. Jarratt, and S. Kempers et al. A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial Br J Dermatol 164 2011 1376 1382
14. D.M. Thiboutot, A.R. Shalita, P.S. Yamauchi, C. Dawson, N. Kerrouche, and S. Arsonnaud et al. Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study Arch Dermatol 142 2006 597 602
15. J.J. Leyden, K.J. McGinley, S. Cavalieri, G.F. Webster, O.H. Mills, and A.M. Kligman Propionibacterium acnes resistance to antibiotics in acne patients J Am Acad Dermatol 8 1983 41 45
16. R.M. Levy, E.Y. Huang, D. Roling, J.J. Leyden, and D.J. Margolis Effect of antibiotics on the oropharyngeal flora in patients with acne Arch Dermatol 139 2003 467 471
17. S.R. Feldman, F.T. Camacho, J. Krejci-Manwaring, C.L. Carroll, and R. Balkrishnan Adherence to topical therapy increases around the time of office visits J Am Acad Dermatol 57 2007 81 83
18. R.B. Haynes, E. Ackloo, N. Sahota, H.P. McDonald, and X. Yao Interventions for enhancing medication adherence Cochrane Database Syst Rev 2 2008 CD000011
19. F.H. Leenen, T.W. Wilson, P. Bolli, P. Larochelle, M. Myers, and S.P. Handa et al. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring Can J Cardiol 13 1997 914 920
20. R. Lott, S.L. Taylor, J.L. O'Neill, D.P. Krowchuk, and S.R. Feldman Medication adherence among acne patients: a review J Cosmet Dermatol 9 2010 160 166
21. T. Lumley, P. Diehr, S. Emerson, and L. Chen The importance of the normality assumption in large public health data sets Annu Rev Public Health 23 2002 151 169
22. Centers for Disease Control and Prevention. Doxycycline shortage. Available from: URL: http://www.cdc.gov/std/treatment/doxycyclineShortage.htm. Accessed December 11, 2013.
23. Department of Health and Human Services, Centers for Disease Control and Prevention. Doxycycline shortage. Available from: URL: http://www.cdc.gov/std/ dstdp/DearColl-January-28-2013.pdf. Accessed December 11, 2013.
24. M. Ozolins, E.A. Eady, A.J. Avery, W.J. Cunliffe, A.L. Po, and C. O'Neill et al. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomized controlled trial Lancet 364 2004 2188 2195
25. C.B. Archer, S.N. Cohen, and S.E. Baron Guidance on the diagnosis and clinical management of acne Clin Exp Dermatol 37 Suppl 2012 1 6
26. H.H. Tan Antibacterial therapy for acne: a guide to selection and use of systemic agents Am J Clin Dermatol 4 2003 307 314
27. J.S. Strauss, D.P. Krowchuk, J.J. Leyden, A.W. Lucky, A.R. Shalita, and E.C. Siegfried et al. Guidelines of care for acne vulgaris management J Am Acad Dermatol 56 2007 651 663
28. R.C. Simpson, D.J. Grindlay, and H.C. Williams What's new in acne? An analysis of systematic reviews and clinically significant trials published in 2010-11 Clin Exp Dermatol 36 2011 840 843 quiz 3-4
29. A.J. Cooper Systematic review of Propionibacterium acnes resistance to systemic antibiotics Med J Aust 169 1998 259 261
30. D.J. Margolis, W.P. Bowe, O. Hoffstad, and J.A. Berlin Antibiotic treatment of acne may be associated with upper respiratory tract infections Arch Dermatol 141 2005 1132 1136
31. D.J. Margolis, M. Fanelli, E. Kupperman, M. Papadopoulos, J.P. Metlay, and S.X. Xie et al. Association of pharyngitis with oral antibiotic use for the treatment of acne: a cross-sectional and prospective cohort study Arch Dermatol 148 2012 326 332
32. J.I. Ross, A.M. Snelling, E. Carnegie, P. Coates, W.J. Cunliffe, and V. Bettoli et al. Antibiotic-resistant acne: lessons from Europe Br J Dermatol 148 2003 467 478
33. J. Leyden, D.M. Thiboutot, A.R. Shalita, G. Webster, K. Washenik, and B.E. Strober et al. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study Arch Dermatol 142 2006 605 612
34. M.E. Porter What is value in health care? N Engl J Med 363 2010 2477 2481